BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21435604)

  • 1. Improving timeliness of and access to primary percutaneous coronary intervention during all hours mission accomplished?
    Ting HH; Nallamothu BK
    JACC Cardiovasc Interv; 2011 Mar; 4(3):279-80. PubMed ID: 21435604
    [No Abstract]   [Full Text] [Related]  

  • 2. Off-hour primary percutaneous coronary angioplasty does not affect outcome of patients with ST-Segment elevation acute myocardial infarction treated within a regional network for reperfusion: The REAL (Registro Regionale Angioplastiche dell'Emilia-Romagna) registry.
    Casella G; Ottani F; Ortolani P; Guastaroba P; Santarelli A; Balducelli M; Menozzi A; Magnavacchi P; Sangiorgi GM; Manari A; De Palma R; Marzocchi A
    JACC Cardiovasc Interv; 2011 Mar; 4(3):270-8. PubMed ID: 21435603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians ... wake up!
    Shah AP; French WJ
    JACC Cardiovasc Interv; 2008 Dec; 1(6):689-91. PubMed ID: 19463385
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality metrics for each component of the STEMI care system.
    Blankenship JC
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):835-6. PubMed ID: 19902504
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-ST-segment elevation myocardial infarction treated at hospitals with and without on-site cardiac surgery: what is the important point?
    Dehmer GJ; Brindis RG
    JACC Cardiovasc Interv; 2009 Oct; 2(10):953-5. PubMed ID: 19850254
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.
    Pride YB; Canto JG; Frederick PD; Gibson CM;
    JACC Cardiovasc Interv; 2009 Oct; 2(10):944-52. PubMed ID: 19850253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with poorer prognosis for patients undergoing primary percutaneous coronary intervention during off-hours: biology or systems failure?
    Glaser R; Naidu SS; Selzer F; Jacobs AK; Laskey WK; Srinivas VS; Slater JN; Wilensky RL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):681-8. PubMed ID: 19463384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of day versus night as intervention time on the outcomes of primary angioplasty for acute myocardial infarction.
    Uyarel H; Ergelen M; Akkaya E; Ayhan E; Demirci D; Gul M; Isik T; Cicek G; Gunaydin ZY; Ugur M; Demirci DE; Turkkan C; Erer HB; Ozturk R; Yekeler I
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):826-34. PubMed ID: 19670313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal reperfusion therapy: when good is never good enough.
    Beygui F; Montalescot G
    Arch Cardiovasc Dis; 2009 Apr; 102(4):253-4. PubMed ID: 19427601
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics and management of acute ST-segment elevation myocardial infarctions occurring in ski resorts in the French Alps: Impact of an acute coronary care network.
    Chacornac M; Baronne-Rochette G; Schmidt MH; Savary D; Habold D; Bouvaist H; Marliere S; Belle L; Machecourt J; Vanzetto G;
    Arch Cardiovasc Dis; 2010; 103(8-9):460-8. PubMed ID: 21074125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing direction in ST-segment elevation myocardial infarction care: where do we go from here?
    Jacobs AK; Hochberg CP
    JACC Cardiovasc Interv; 2010 Jul; 3(7):712-4. PubMed ID: 20650432
    [No Abstract]   [Full Text] [Related]  

  • 12. Completeness of revascularization in patients with ST-Elevation acute myocardial infarction.
    Kornowski R
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):934-6. PubMed ID: 19016458
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical outcome of patients with diabetes presenting with ST-elevation myocardial infarction and treated with concomitant use of glycoprotein IIb/IIIa inhibitors.
    Kralev S; Krause B; Papavassiliu T; Lang S; Haghi D; Kälsch T; Dempfle CE; Borggrefe M; Süselbeck T
    Cardiol J; 2009; 16(3):234-40. PubMed ID: 19437397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bypass surgery after non-ST-segment elevation myocardial infarction better early than late?
    Anderson JL; Doty JR
    JACC Cardiovasc Interv; 2010 Apr; 3(4):428-30. PubMed ID: 20398871
    [No Abstract]   [Full Text] [Related]  

  • 15. Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.
    Heestermans T; de Boer MJ; van Werkum JW; Mosterd A; Gosselink AT; Dambrink JH; van Houwelingen G; Koopmans P; Hamm C; Zijlstra F; ten Berg JM; van 't Hof AW
    EuroIntervention; 2011 Aug; 7(4):442-8. PubMed ID: 21764662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary percutaneous coronary intervention for patients presenting with ST-segment elevation myocardial infarction: process improvement in a rural ST-segment elevation myocardial infarction receiving center.
    Niles NW; Conley SM; Yang RC; Vanichakarn P; Anderson TA; Butterly JR; Robb JF; Jayne JE; Yanofsky NN; Proehl JA; Guadagni DF; Brown JR;
    Prog Cardiovasc Dis; 2010; 53(3):202-9. PubMed ID: 21130917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Garg S; Sarno G; Serruys PW; Rodriguez AE; Bolognese L; Anselmi M; De Cesare N; Colangelo S; Moreno R; Gambetti S; Monti M; Bristot L; Bressers M; Garcia-Garcia HM; Parrinello G; Campo G; Valgimigli M;
    JACC Cardiovasc Interv; 2011 Jan; 4(1):66-75. PubMed ID: 21251631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary percutaneous coronary intervention for patients presenting with ST-elevation myocardial infarction: process improvements in rural prehospital care delivered by emergency medical services.
    Rezaee ME; Conley SM; Anderson TA; Brown JR; Yanofsky NN; Niles NW
    Prog Cardiovasc Dis; 2010; 53(3):210-8. PubMed ID: 21130918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous coronary intervention: paradise lost or paradise renamed?
    Henry TD; Larson DM
    JACC Cardiovasc Interv; 2009 Oct; 2(10):931-3. PubMed ID: 19850251
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trials.
    Valgimigli M; Campo G; Malagutti P; Anselmi M; Bolognese L; Ribichini F; Boccuzzi G; de Cesare N; Rodriguez AE; Russo F; Moreno R; Biondi-Zoccai G; Penzo C; Díaz Fernández JF; Parrinello G; Ferrari R
    JACC Cardiovasc Interv; 2011 Jan; 4(1):51-62. PubMed ID: 21251629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.